A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee
Sengupta K, Alluri KV, Satish AR, et al.
Published in Arthritis Research & Therapy
Abstract
Double-blind randomized placebo-controlled trial of 5-Loxin Boswellia serrata extract in knee osteoarthritis.
Key Findings
5-Loxin Boswellia extract reduced knee pain and improved physical function versus placebo within 7 days, with reductions in synovial fluid matrix metalloproteinase-3.
Conclusions
A standardized Boswellia extract provides rapid symptomatic relief in knee osteoarthritis.
Limitations
Small sample, 90-day duration, manufacturer-sponsored.
Supplements Studied
5-Loxin Boswellia extract reduced knee pain and improved physical function versus placebo within 7 days, with reductions in synovial fluid matrix metalloproteinase-3.
Outcomes Measured
5-Loxin Boswellia extract reduced knee pain and improved physical function versus placebo within 7 days, with reductions in synovial fluid matrix metalloproteinase-3.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.